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Allelic Variation in the TNF-ß Gene Does Not 
Explain the Low TNF-ß Response in Patients 
With Primary Biliary Cirrhosis 
G . M E S S E R , U . S P E N G L E R * , M . C . J U N G , G . H O N O L D , 
J . E I S E N B U R G f , S. S C H O L Z } , E . D . A L B E R T } , G . R . P A P E * , 
G . R I E T H M Ü L L E R & E . H . W E I S S 
Institute of Immunology and * I I . Department of Internal Medicine, Klinikum Gro/?hadern, 
University of Munich, tKrankenhaus d. Barmherzigen Brüder, and ^Laboratory of 
Immunogenetics, University of Munich, Munich, Germany 
Messer G, Spengler U , Jung M C , Honold G, Eisenburg J, Scholz S, Albert ED, Pape GR, 
Riethmüller G, Weiss EH. Allelic Variation in the TNF-/? Gene Does Not Explain the Low T N F -
/? Response in Patients With Primary Biliary Cirrhosis. Scand J Immunol 1991;34:735 -40 
Autoimmune disorders in humans are often associated with particular alleles of major 
histocompatibility genes. However, the chronic inflammatory liver disease primary biliary 
cirrhosis (PBC) has not been found to be correlated with certain haplotypes so far. 
Interestingly, an impaired production of tumour necrosis factor ß (TNF-/?) upon mitogen 
stimulation was observed for PBC patients, especially in the immunologically active stages of the 
disease. Furthermore, the identification of alleles of the TNF-/? gene which differ in one unique 
amino acid, and in the production of TNF-/? after phytohaemagglutinin stimulation, has 
prompted the idea of a possible linkage between the impaired TNF-/? response in PBC and the 
genetic prevalence of a certain T N F haplotype. 
We report here a rapid method for typing the TNFB*1 and TNFB*2 genes by a standard 
polymerase chain reaction. PBC patients (n = 60) as well as randomized healthy controls {n = 179) 
of the Munich area were studied for the occurrence of the T N F alleles. No deviation was found in 
the PBC collective (0.7) for the TNFB*2 distribution when compared with the control (0.67). 
Dr Elisabeth II, Weiss, Institute of Immunology, University oj Munich, Gocthestr. 31, W-8000 
München 2, Germany 
Primary biliary cirrhosis (PBC) is a chronic 
cholestatic liver disease of unknown aetiology 
characterized by the destruction of intrahepatic 
bile ducts. Tissue damage is thought to be the 
result of an autoimmune process [1-5]. The 
disease is associated with many immunological 
defects including autoantibodies [6-10] and T 
lymphocyte immunoregulatory abnormalities 
which involve both CD4 * and C D 8 + cells [5, 11, 
12]. We have recently shown that T lymphocytes 
and T-cell lines from patients with PBC produce 
much lower amounts of tumour necrosis factor /? 
(lymphotoxin, TNF-/?) in response to phyto-
haemagglutinin (PHA) than T cells of controls 
[13, 14]. Since reduced inducibility of TNF-/? in 
PBC patients was also reflected in the amount of 
TNF-/? mRNA produced, this dysregulation 
must be controlled at least in part at the level of 
transcription. 
The localization of the tumour necrosis factor 
genes between the major histocompatibility com-
plex (MHC) class I and class I I I loci [15-18] has 
prompted the idea that a polymorphism of the 
T N F genes might be linked to autoimmune 
diseases. Several groups have investigated poss-
ible associations between M H C genes and PBC 
[19-22], but no strong associations with class I or 
class I I loci have been found so far. 
We have recently characterized two TNF-/? 
alleles (TN FB* 1 and TNFB*2) distinguished by a 
polymorphic Nco\ restriction site in the first 
intron of the TNF-/? gene, which differ in primary 
structure and in the inducibility upon stimulation 
with PHA [23]. The TNFB*1 allele (5.3-kb Nco\ 
735 
736 G. Messer et al. 
TNF-/? gene fragment) codes for asparagine at 
position 26 and presents with a significantly 
higher TNF-/J m R N A and protein synthesis upon 
stimulation of peripheral blood mononuclear 
cells than the TNFB*2 allele (11-kb Ncol TNF-/? 
gene fragment) coding for threonine at position 
26. 
We analysed a large panel of PBC patients in 
order to find out whether the reduced TNF-/? 
response of these patients might be linked with 
the TNFB*2 allele. In addition, we present a 
rapid method for typing the TNF-/? Nco\ poly-
morphism and the result of a collective of 60 
caucasoid PBC patients from the Munich area 
compared with 179 healthy individuals. 
M A T E R I A L S A N D M E T H O D S 
DNA extraction and RFLP typing. D N A was 
extracted from fresh or cryopreserved peripheral blood 
lymphocytes either by lysis in 4 M guanidinium thiocya-
nate followed by phenol/chloroform/isoamylalcohol 
extraction and ethanol precipitation or alternatively by 
protease K digestion, NaCl precipitation of peptide 
debris and ethanol precipitation of the chromosomal 
D N A . For genomic southern blot analysis, 10 //g of 
D N A was digested with the restriction enzyme Nco\. 
The digests were separated on a 0.7% agarose gel, 
transferred to a nylon membrane (Hybond-N + , Amer-
sham & Buchler, Braunschweig, Germany) and hybri-
dized with the 2.4-kb TNF-/? EcoRl fragment detecting 
either a 1 1 -kb Nco\ fragment or a 5.7-kb and a 5.3-kb 
Nco\ fragment [23]. 
For polymerase chain reaction (PCR) typing of the 
TNF7-/? Nco\ restriction fragment length polymorphism 
(RFLP), the following primers were used: TNF-/?L (5'-
C C G T G C T T C G T G C T T T G G ACTA-3 ' ) located in 
the 5' untranslated region, and TNF-/?R (5'-
A G A G C T G G T G G G G A C A T G T C T G - 3 ) within the 
second intron of the TNF-/? gene (see Fig. 1), resulting 
in the amplification of a fragment o f 740 bp. The 
amplification was carried out in a 20 p\ reaction for 30 
cycles with 0.5 to 1.0 fig genomic D N A and 1.4 U Taq 
polymerase (Amersham & Buchler) in a Hybaid ther-
mocycler (Biometra, Göt t ingen , Germany). The initial 
denaturation step was increased to 6 min and each PCR 
cycle contained 1 min of denaturation, I min of 
annealing at 55 C and 1 min of extension reaction at 
72 C. For optimal amplification the M g 2 + concentra-
tion of the reaction buffer was adjusted to 1 m M [24]. 
Five microlitres o f amplification product were restricted 
in 50 / i l o f Ncol reaction buffer with 0.5 U of the enzyme 
Nco\ and loaded on a 1.5% agarose gel. The presence of 
the Nco\ recognition sequence in intron 1 o f the TNF-/? 
gene ( T N F B * I allele) resulted in two cleavage products 
of 555 bp and 185 bp, whereas the TNFB*2 allele was 
detected as the intact amplified 740-bp fragment. In the 
study, control genomic D N A samples homozygous for 
either one or the other T N F B allele were amplified and 
restricted in parallel with the samples tested. Eight 
individuals of the controls and 9 patients of the PBC 
group were tested both by digestion of genomic D N A 
and by RFLP analysis of the PCR amplification 
product, and no deviation was detected. 
Patients and controls. Six male and 54 female patients 
of PBC aged 32 to 64 years were collected from two 
referral centres of the Munich area. Diagnosis of PBC 
was established by clinical, biochemical and histological 
criteria and all patients had significant titres of antimi-
tochondrial autoantibodies. Additional criteria for his-
tological staging were employed according to Scheuer 
[25]. 
As the control group, 179 healthy, unselected and 
unrelated individuals were typed for the T N F B Ncol 
RFLP, either by genomic southern blot analyses or by 
PCR typing. Owing to the random selection, the 
distribution of females versus males was equal. 
HLA serology. H L A typing for H L A - A , -B. -C 
antigens was carried out by standard microlymphotoxi-
city testing. Twenty-nine PBC patients and 44 indi-
viduals of the control group were typed for H L A class I 
and I I antigens. Allele frequencies were compared with 
data from reference tables [26]. 
Statistical analyses. T N F B allele frequencies (Table 
I) were calculated by gene counting of the observed 
phenolypes. The control group was analysed by Hardy-
Weinberg equilibrium and presented no significant 
deviation. Relative risks were estimated according to 
Haldane's formula. Contingency tables were analysed 
by the Chi-square test [19]. 
R E S U L T S 
Amplification of a 740-bp exon 1 /intron 3 carry-
ing fragment of the human TNF-/? gene was 
performed from genomic D N A (Fig. I ) . The 
amplification primers were chosen such that the 
Ncol restriction site was in an excentric position. 
Thus, amplification and Ncol restriction of the 
TNFB*1 allele resulted in two fragments of 185 
bp and 555 bp in length. The T N F B phenotype 
frequencies of 179 healthy, randomly selected 
individuals are given in Table I . The gene frequen-
cies were 0.33 for the TNFB*1 allele and 0.67 for 
TNFB*2. No deviation from the expectations 
according to Hardy-Weinberg equilibrium was 
found. The distribution of the T N F B alleles did 
not differ significantly between female and male 
individuals. 
In PBC patients, no difference in the frequency 
of TNFB* 1 phenotypes (10%) was found com-
pared with the control (11.2%) (see Table I , in 
brackets). Heterozygosity was decreased (40%) 
and the TNFB*2 phenotype was increased in the 
patients (50%) compared with the controls 
(43.6% and 45.2%. respectively). The overall 




FIG. 1. Strategy for PCR-typing of the Nco\ RFLP of the human T N F - / ? gene. The 
genomic structure of the linked human TNF-/? and TNF-a genes is shown in A . Exons are 
indicated as black boxes with the numbers above. The position and the sequence of the 
oligonucleotide primers used for PCR amplification of genomic D N A resulting in a 740-
bp fragment are depicted underneath. The open triangle indicates the Nco\ restriction site 
present in the first intron of the TNFB*1 allele. 
Fig. 1 B shows the result of the /Va;I-restricted products obtained from 18 different PBC 
patients. The 1-kb molecular weight marker (BRL, Karlsruhe, Germany) was co-
electrophoresed in the last lane on the right. The sizes of the fragments after Ncol 
restriction are given on the right side (740 bp for the TNFB*2 allele; 555 bp and 185 bp for 
the T N F B * I allele). The patient four from the left is homozygous for the TNFB*1 allele. 
distribution of the TNFB*1 allele was insignifi-
cantly reduced in PBC (0.3) compared with the 
controls (0.33), and the relative risk of 1.16 for the 
TNFB*2 allele did not reveal an association of 
the more frequently found TNFB*2 allele to the 
disease. To further evaluate whether a correlation 
with H L A haplotypes could be found, we investi-
gated H L A class I and class I I antigens in the 
patients who were available for typing (PBC 
/7 = 29, and control n — 44). H L A typing of the 
patients did not show a strong association of 
specific HLA haplotypes with PBC (data not 
shown). In general, a similar increase for certain 
H L A class I antigens has been observed as 
previously reported by Prochazka et al. [22]. Gene 
frequencies in the control group were identical to 
those obtained by the population analysis of Baur 
et al. (in Ref. 26), demonstrating that no bias due 
to the sampling procedure was present. 
D I S C U S S I O N 
The high frequency of HLA-B8 and H L A - D R 3 
antigens among patients with autoimmune dis-
eases, and the tight linkage of the TNFB*1 allele 
with the B8-DR3 haplotype [27-29], has raised 
the possibility that variations of the T N F genes 
might be related to the individual disease suscep-
tibilities. Thus, several groups have studied the 
association of the diallelic Nco\ RFLP indicative 
for the two TNF-/? alleles, although often only a 
small collective of patients, with the following 
diseases: diabetes mellitus ( I D D M , Refs 27-29), 
Grave's disease [30], systemic lupus erythemato-
sus (SLE), pauciarticular juvenile rheumatoid 
arthritis (P-JRA), rheumatoid arthritis (RA) and 
primary Sjogren's syndrome (pSS, Ref. 31). No 
increase in the frequency of one allele was found 
when comparing with HLA-matched controls. 
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TABLE: I . Distribution of the T N F B phcnotypcs in 60 patients 
with PBC (primary biliary cirrhosis) in comparison to 179 
healthy randomly selected individuals. The phcnolype is 
given in numbers and as calculated percentage (in brackets). 
Expected values of the control group are calculated accord-
ing to the Hardy-Weinbcrg equilibrium for the distribution 
of the T N F B * 1 and TNFB*2 alleles and are given under the 
observed number. The gene frequencies of T N F B * I and 
TNFB*2 are given underneath. Relative risk for PBC in the 
TNFB*2 group ( R R = 1 . I ) is calculated by Haldane's for-
mula; the 2 x 2 tables are calculated as shown in Tiwari & 
Terasaki [19]. 
TNFB*1 T N F B * 12 T N F B * 2 
PBC 6(10%) 24(40%) 30(50%) 
(/? = 60) 0.3 0.7 
Controls 20(11.2%) 78 (43.6%) 81 (45.2%) 
Expected 19.5(10.8%) 78.8 (44.2%) 80.4(44.9%) 
(/i =179) 0.33 0.67 
Chi-square = 0.4; />>0.05. 
Only a higher number of heterozygotes among 
patients with I D D M was observed [27. 29]. When 
additional HLA-associated susceptibilities such 
as ankylosing spondylitis [32, 33], Hashimoto's 
thyroiditis [34], multiple sclerosis and optic neuri-
tis [35] were analysed, again no significant devia-
tion in gene or phenotype frequencies was found. 
Although no strong association was detected 
between H L A alleles with PBC, the possibility 
remained that the presence of a particular T N F 
allele might contribute to the pathogenesis of the 
disease. Fugger et al. reported a significantly 
decreased frequency of the TNFB*2 allele in 22 
patients with PBC [36]. The analysis of 60 patients 
presented here demonstrates no association of 
one particular TNF-/? allele with the disease. The 
gene frequencies are the same as in the control 
group and in agreement with the distribution 
described in previous reports [27, 29, 32, 36]. 
Thus, no association can be found between PBC 
and the Nco\ RFLP. The question has been raised 
as to whether differences exist in the T N F genes 
between healthy individuals and patients which 
cannot be detected by RFLP analyses. In our 
study of the linkage of the Nco\ RFLP with the 
amino acid substitution at position 26 and of the 
TNF-a promoter region, we have amplified and 
sequenced the relevant segments of PBC patients, 
homozygous for the Nco\ RFLP (5 patients for 
the 5' gene segment of the TNF-/? gene and 3 
patients for the TNF-a gene promoter), and no 
further nucleotide differences have been found 
[23]. 
The results presented here argue against a 
particular TNF-/? allele being involved in the 
pathogenesis of PBC. Moreover, the observed 
low production of TNF-/? mRNA and protein in 
patients with PBC [5, 13, 14] cannot be explained 
by a unique structure of the TNF-/? gene in 
patients, but might be caused by a disease-specific 
inability in the activation of transcription factors 
regulating TNF-/? gene expression. In this con-
text, it was of interest to learn that the low TNF-/? 
response of T lymphocytes derived from PBC 
patients may be due to the low interlcukin 2 (IL-2) 
production by these cells [37]. Moreover, mice 
used as model systems for autoimmune diseases 
( N Z B x N Z W ) F l in which autoimmunity has 
been attributed to low TNF-a synthesis [38], or 
M R L / L p r mice, might also have a reduced IL-2 
response [39-41]. 
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